Literature DB >> 28537100

Cerebrospinal fluid neurofilament light levels mark grey matter volume in clinically isolated syndrome suggestive of multiple sclerosis.

Carla Tortorella1, Vita Direnzo1, Maddalena Ruggieri1, Stefano Zoccolella1, Mariangela Mastrapasqua1, Mariangela D'Onghia1, Damiano Paolicelli1, Franca Di Cuonzo1, Claudio Gasperini2, Maria Trojano1.   

Abstract

BACKGROUND: Brain atrophy is a known marker of irreversible tissue damage in multiple sclerosis (MS). Cerebrospinal fluid (CSF) osteopontin (OPN) and neurofilament light chain (NF-L) have been proposed as candidate surrogate markers of inflammatory and neurodegenerative processes in MS.
OBJECTIVE: To evaluate the relationship between CSF NF-L and OPN levels and brain grey and white matter volumes in patients with clinically isolated syndrome (CIS) suggestive of MS.
METHODS: A total of 41 CIS patients and 30 neurological controls (NCs) were included. CSF NF-L and OPN were measured by commercial ELISA. Measures of brain volume (normalized brain volume (NBV), normalized grey matter volume (NGV), peripheral grey matter volume (PGV), normalized white matter volume (WMV), and ventricular volume) were obtained by SIENAX. Corpus callosum index (CCI) was calculated. Brain volumes were categorized into 'high' and 'low' according to the median value.
RESULTS: CSF NF-L and OPN levels were higher in CIS patients in comparison with NCs. CIS patients with 'low' TGV, PGV, and TBV showed higher CSF NF-L levels than CIS patients with 'high' brain volumes. TGV and PGV correlated inversely with NF-L levels, whereas CCI was inversely related to OPN levels. CSF NF-L was the only independent predictor of TGV and PGV.
CONCLUSION: CSF NF-L tracks mainly grey matter damage in patients with CIS suggestive of MS.

Entities:  

Keywords:  Clinically isolated syndromes; brain volume; neurofilament; osteopontin

Mesh:

Substances:

Year:  2017        PMID: 28537100     DOI: 10.1177/1352458517711774

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  6 in total

Review 1.  Serum-Based Biomarkers in Neurodegeneration and Multiple Sclerosis.

Authors:  Patrizia LoPresti
Journal:  Biomedicines       Date:  2022-05-06

2.  ISGylation is induced in neurons by demyelination driving ISG15-dependent microglial activation.

Authors:  Benjamin D S Clarkson; Ethan Grund; Kenneth David; Renee K Johnson; Charles L Howe
Journal:  J Neuroinflammation       Date:  2022-10-20       Impact factor: 9.587

Review 3.  Neurofilament light chain as a biological marker for multiple sclerosis: a meta-analysis study.

Authors:  Laisheng Cai; Jingwei Huang
Journal:  Neuropsychiatr Dis Treat       Date:  2018-09-03       Impact factor: 2.570

4.  Serum NfL levels in the first five years predict 10-year thalamic fraction in patients with MS.

Authors:  Hrishikesh Lokhande; Mattia Rosso; Shahamat Tauhid; Renxin Chu; Brian C Healy; Shrishti Saxena; Christian Barro; Anu Paul; Mariann Polgar-Turcsanyi; Mark Anderson; Bonnie I Glanz; Harald Kropshofer; Cristina Granziera; David Leppert; Ludwig Kappos; Jens Kuhle; Howard L Weiner; Rohit Bakshi; Tanuja Chitnis
Journal:  Mult Scler J Exp Transl Clin       Date:  2022-01-10

5.  Osteopontin levels are associated with late-time lower regional brain volumes in multiple sclerosis.

Authors:  Gergely Orsi; Zsofia Hayden; Tamas Cseh; Timea Berki; Zsolt Illes
Journal:  Sci Rep       Date:  2021-12-08       Impact factor: 4.379

6.  CSF neurofilament light chain predicts 10-year clinical and radiologic worsening in multiple sclerosis.

Authors:  Alok Bhan; Cecilie Jacobsen; Ingvild Dalen; Niels Bergsland; Robert Zivadinov; Guido Alves; Kjell-Morten Myhr; Elisabeth Farbu
Journal:  Mult Scler J Exp Transl Clin       Date:  2021-12-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.